To answer your question, yes, if that's all there is, I would...

To answer your question, yes, if that's all there is, I would expect the market to shrug it off, but if there is a deal in there somewhere, then the result will be different. - but only after a deal is announced. I am sure that there are some potential partners waiting for these results. Whether they find them meaningful enough is another question.

BTW, any human trials will likely be able to go straight to a Phase 2b and quickly to Phase 3, since the safety profile has been established already at great expense.

But true, at this point, the Metabolic side of the house remains more speculative.